Galmed Pharmaceuticals Ltd. announced that it has appointed Liat Hayardeny, Ph.D., MBA, as Chief Scientific Officer, effective as of September 7, 2016. Dr. Hayardeny joins Galmed with 16 years of experience in drug development in the global R&D division at Teva Pharmaceuticals, where she served as Senior Director, Head of Research Scientific Affairs.